Korean J Otolaryngol-Head Neck Surg.  2005 May;48(5):641-645.

Analysis of c-Kit Gene Polymorphism in NK/T Cell Lymphoma in Korean Population

Affiliations
  • 1Department of Otolaryngology-Head and Neck Surgery, Korea University College of Medicine, Seoul, Korea. entkwon@chollian.net
  • 2Jeil ENT Clinic, Seoul, Korea.

Abstract

BACKGROUND AND OBJECTIVES
The proto-oncogene c-KIT encodes a receptor tyrosine kinase (KIT) whose ligand is a stem cell factor. KIT is expressed and critical for the development and growth of mast cells, melanocytes, hematopoetic stem cells, and the interstitial cells of Cajal. In this study, c-kit gene mutations were analyzed in 27 cases of NK/T cell lymphoma. SUBJECTS AND METHODS: During 1995 to 2002, 27 patients with NK/T cell lymphoma in the head and neck area were selected for this study. The nasal cavity were predominant sites (15 cases), followed by 6 nasopharynx cases, 4 tonsil 4 cases, and 2 hard palate cases. Gene mutation was analyzed by PCR-SSCP and direct sequencing. RESULTS: c-kit gene mutation was found in 5 of 27 cases by the PCR-SSCP method. Among the 5 cases, 2 cases exhibited no mutation by direct sequencing. Consequently, the mutation of c-kit gene was detected in 3 of 27 cases. CONCLUSION: The frequency of c-kit gene mutation (11%) indicated in the present cases is lower than that reported in north China but higher than that in Japan.

Keyword

T cell lymphoma; Natural killer cell; Proto-oncogene protein c-kit

MeSH Terms

China
Growth and Development
Head
Humans
Interstitial Cells of Cajal
Japan
Killer Cells, Natural
Lymphoma*
Lymphoma, T-Cell
Mast Cells
Melanocytes
Nasal Cavity
Nasopharynx
Neck
Palate, Hard
Palatine Tonsil
Protein-Tyrosine Kinases
Proto-Oncogene Proteins c-kit
Proto-Oncogenes
Stem Cell Factor
Stem Cells
Protein-Tyrosine Kinases
Proto-Oncogene Proteins c-kit
Stem Cell Factor
Full Text Links
  • KJORL-HN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr